MedPath

To see the prevalence of Knee osteoarthritis and to evaluate the effect of Hijamah bila Shart (Dry Cupping) in the cases of Knee osteo-arthritis.

Phase 2
Conditions
Health Condition 1: M179- Osteoarthritis of knee, unspecified
Registration Number
CTRI/2021/08/035633
Lead Sponsor
Jamia Hamdard
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

•Diagnosed patients of knee OA in age groups of 35 to 65 years.

•Subjective pain intensity of 5mmto 74mm (mild to moderate pain) baseline on Visual Analogue Scale (VAS).

•Grade 2and grade 3 osteoarthritis in X-ray film. (Kellgren and Lawrence)

•Clinically stable patients.

•ESR <40mm/hr

•Rheumatoid factors (RF) <1:40

•Patients of all genders.

•Patients who are willing to sign the informed consent form and participate in the trial voluntarily.

Exclusion Criteria

•Age below 35 and above 65.

•ESR > 40mm/hr.

•Rheumatoid factors (RF) >1:40

• < Grade 2 and >grade 3osteoarthritis in X-ray film.(Kellgren and Lawrence)

•Patients with uncontrolled DM, Hepatic, Renal or CVS disorders.

•Patient on anticoagulant therapy or Haemophiliacs

•Pregnant and lactating mothers.

•Subjects who are chronically ill patient with infectious diseases like AIDS and Tuberculosis etc.

•Patients who fail to give written consent.

•Patients taking analgesic or anti-inflammatory drugs for any other disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual Analogue Scale (VAS) <br/ ><br>Knee Injury And Osteoarthritis Outcome Score (KOOS) <br/ ><br>Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Index (Modified â?? CRD Pune Version) <br/ ><br>Timepoint: Baseline, 28th day
Secondary Outcome Measures
NameTimeMethod
Prevalence of Knee OA in the total number of patients reporting at the registration counter of the HospitalTimepoint: At the end of three months
© Copyright 2025. All Rights Reserved by MedPath